Advertisement
Screener

OCUGEN, INC. (OCGN) Net Margin

OCUGEN, INC. (OCGN) Net Margin

  • 2026-06-30: Net Margin -1671.84%.
  • 2026-03-31: Net Margin -1250.95%.
  • 2025-12-31: Net Margin 9174.09%.
  • 2025-09-30: Net Margin -1144.46%.

Complete source-backed net margin history.

Available history
2020-06-30 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-1671.84%
2026-03-31-1250.95%
2025-12-319174.09%
2025-09-30-1144.46%
2025-06-30-1073.49%
2025-03-31-1036.46%
2024-12-31-1816.75%
2024-09-30-1141.73%
2024-06-30-1339.18%
2024-03-31-1175.94%
2023-12-31-778.57%
2023-09-30-316.76%
2023-06-30-4755.67%
2023-03-31-3911.06%
2022-12-31-2547.67%
2020-06-30-8404.65%

Annual Net Margin

DateNet Margin
2025-12-31-1537.41%
2024-12-31-1333.02%
2023-12-31-1045.03%
2022-12-31-3488.91%
2020-12-31-50748.84%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02
SAB Biotherapeutics, Inc. (SABS)United States$0.306B-25.49
AGENUS INC (AGEN)United States$0.383B1.41
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
Surrozen, Inc./DE (SRZN)United States$0.395B